CA Stock MarketDetailed Quotes

IPCI.H IntelliPharmaCeutics International Inc

Watchlist
  • 0.080
  • 0.0000.00%
15min DelayMarket Closed Mar 5 10:01 ET
2.65MMarket Cap-0.66P/E (TTM)

IntelliPharmaCeutics International Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
(Q2)May 31, 2022
(Q1)Feb 28, 2022
(FY)Nov 30, 2021
(Q4)Nov 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
182.15%240.83K
126.50%89.73K
97.47%-14.18K
43.60%-1.39M
41.65%-195.93K
78.48%-293.15K
55.67%-338.57K
-90,080.90%-560.58K
-2,295.50%-2.46M
45.57%-335.75K
Net income from continuing operations
-547.96%-1.89M
93.56%-54.12K
59.62%-355.74K
43.78%-2.89M
55.05%-879.2K
76.94%-291.57K
15.95%-840.65K
4.72%-880.97K
-51.73%-5.15M
-20.59%-1.96M
Operating gains losses
236.91%7.79K
97.90%-10.47K
-100.42%-5
-2,616.09%-50.2K
27,008.78%453.68K
43.11%-5.69K
-4,288.65%-499.37K
-32.82%1.18K
-98.09%2K
-102.10%-1.69K
Depreciation and amortization
-21.08%40.63K
-21.24%40.55K
-20.86%40.74K
-21.21%206.06K
-21.04%51.62K
-21.26%51.48K
-21.26%51.48K
-21.27%51.48K
-37.04%261.53K
-39.46%65.38K
Asset impairment expenditure
----
----
----
--0
----
----
----
----
33.49%627.17K
----
Remuneration paid in stock
----
----
----
--0
----
----
----
----
-83.27%11.99K
--0
Deferred tax
----
----
----
94.12%-5.52K
----
----
----
----
---93.85K
----
Other non cashItems
2,498.20%4.01K
-131.34%-6.68K
115.35%11.39K
-81.48%83.72K
-90.62%13.49K
-100.09%-167
-58.98%21.32K
-222.55%-74.21K
-40.91%451.92K
238.71%143.8K
Change In working capital
4,501.58%2.08M
-87.03%120.46K
-15.35%289.44K
-10.75%1.27M
-80.67%170K
86.48%-47.2K
778.60%928.65K
-56.55%341.94K
-15.15%1.42M
182.09%879.53K
-Change in receivables
--333.58K
-426.76%-122.06K
-464.68%-210.93K
-100.08%-602
-100.28%-602
--0
131.32%37.35K
-106.59%-37.35K
337.23%780.34K
274.86%213.96K
-Change in prepaid assets
-102.00%-1.21K
-115.74%-6.3K
81.19%-46.11K
-245.29%-77.82K
-24.44%66.99K
187.36%60.32K
1,182.41%40.01K
-751.34%-245.13K
31.06%53.56K
891.96%88.66K
-Change in payables and accrued expense
1,524.44%1.53M
-70.77%248.81K
9.04%546.47K
128.88%1.35M
-78.08%103.61K
70.70%-107.52K
224.61%851.29K
126.49%501.14K
-70.02%589.19K
-13.70%472.67K
-Change in other current liabilities
----
----
--0
----
----
----
----
421.53%123.28K
----
----
-Change in other working capital
--213.73K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
182.15%240.83K
126.50%89.73K
97.47%-14.18K
43.60%-1.39M
41.65%-195.93K
78.48%-293.15K
55.67%-338.57K
-90,080.90%-560.58K
-2,295.50%-2.46M
45.57%-335.75K
Investing cash flow
Cash flow from continuing investing activities
0
0
500K
0
0
500K
0
0
Net PPE purchase and sale
--0
--0
----
--500K
--0
--0
--500K
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
----
--500K
--0
--0
--500K
----
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-93.40%200K
3.03M
0
Net issuance payments of debt
----
----
----
--200K
----
----
----
----
--0
----
Net common stock issuance
----
----
----
--0
----
----
----
----
--3.07M
--0
Net other financing activities
----
----
----
----
----
----
----
----
---38.22K
--0
Cash from discontinued financing activities
Financing cash flow
----
----
----
-93.40%200K
----
----
----
----
--3.03M
--0
Net cash flow
Beginning cash position
-57.28%159.27K
-67.10%69.55K
-89.15%83.72K
282.06%771.95K
-92.81%79.65K
-84.91%372.8K
4.29%211.36K
282.06%771.95K
212.66%202.05K
38.71%1.11M
Current changes in cash
182.15%240.83K
-44.42%89.73K
97.47%-14.18K
-220.76%-688.22K
101.21%4.07K
78.48%-293.15K
-92.88%161.43K
-90,080.90%-560.58K
314.70%569.9K
43.71%-335.75K
End cash Position
402.33%400.1K
-57.28%159.27K
-67.10%69.55K
-89.15%83.72K
-89.15%83.72K
-92.81%79.65K
-84.91%372.8K
4.29%211.36K
282.06%771.95K
282.06%771.95K
Free cash from
182.15%240.83K
126.50%89.73K
97.47%-14.18K
43.60%-1.39M
41.65%-195.93K
78.48%-293.15K
55.67%-338.57K
-90,080.90%-560.58K
-2,374.10%-2.46M
45.57%-335.75K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022(Q2)May 31, 2022(Q1)Feb 28, 2022(FY)Nov 30, 2021(Q4)Nov 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 182.15%240.83K126.50%89.73K97.47%-14.18K43.60%-1.39M41.65%-195.93K78.48%-293.15K55.67%-338.57K-90,080.90%-560.58K-2,295.50%-2.46M45.57%-335.75K
Net income from continuing operations -547.96%-1.89M93.56%-54.12K59.62%-355.74K43.78%-2.89M55.05%-879.2K76.94%-291.57K15.95%-840.65K4.72%-880.97K-51.73%-5.15M-20.59%-1.96M
Operating gains losses 236.91%7.79K97.90%-10.47K-100.42%-5-2,616.09%-50.2K27,008.78%453.68K43.11%-5.69K-4,288.65%-499.37K-32.82%1.18K-98.09%2K-102.10%-1.69K
Depreciation and amortization -21.08%40.63K-21.24%40.55K-20.86%40.74K-21.21%206.06K-21.04%51.62K-21.26%51.48K-21.26%51.48K-21.27%51.48K-37.04%261.53K-39.46%65.38K
Asset impairment expenditure --------------0----------------33.49%627.17K----
Remuneration paid in stock --------------0-----------------83.27%11.99K--0
Deferred tax ------------94.12%-5.52K-------------------93.85K----
Other non cashItems 2,498.20%4.01K-131.34%-6.68K115.35%11.39K-81.48%83.72K-90.62%13.49K-100.09%-167-58.98%21.32K-222.55%-74.21K-40.91%451.92K238.71%143.8K
Change In working capital 4,501.58%2.08M-87.03%120.46K-15.35%289.44K-10.75%1.27M-80.67%170K86.48%-47.2K778.60%928.65K-56.55%341.94K-15.15%1.42M182.09%879.53K
-Change in receivables --333.58K-426.76%-122.06K-464.68%-210.93K-100.08%-602-100.28%-602--0131.32%37.35K-106.59%-37.35K337.23%780.34K274.86%213.96K
-Change in prepaid assets -102.00%-1.21K-115.74%-6.3K81.19%-46.11K-245.29%-77.82K-24.44%66.99K187.36%60.32K1,182.41%40.01K-751.34%-245.13K31.06%53.56K891.96%88.66K
-Change in payables and accrued expense 1,524.44%1.53M-70.77%248.81K9.04%546.47K128.88%1.35M-78.08%103.61K70.70%-107.52K224.61%851.29K126.49%501.14K-70.02%589.19K-13.70%472.67K
-Change in other current liabilities ----------0----------------421.53%123.28K--------
-Change in other working capital --213.73K------------------------------------
Cash from discontinued investing activities
Operating cash flow 182.15%240.83K126.50%89.73K97.47%-14.18K43.60%-1.39M41.65%-195.93K78.48%-293.15K55.67%-338.57K-90,080.90%-560.58K-2,295.50%-2.46M45.57%-335.75K
Investing cash flow
Cash flow from continuing investing activities 00500K00500K00
Net PPE purchase and sale --0--0------500K--0--0--500K------0--0
Cash from discontinued investing activities
Investing cash flow --0--0------500K--0--0--500K------0--0
Financing cash flow
Cash flow from continuing financing activities -93.40%200K3.03M0
Net issuance payments of debt --------------200K------------------0----
Net common stock issuance --------------0------------------3.07M--0
Net other financing activities -----------------------------------38.22K--0
Cash from discontinued financing activities
Financing cash flow -------------93.40%200K------------------3.03M--0
Net cash flow
Beginning cash position -57.28%159.27K-67.10%69.55K-89.15%83.72K282.06%771.95K-92.81%79.65K-84.91%372.8K4.29%211.36K282.06%771.95K212.66%202.05K38.71%1.11M
Current changes in cash 182.15%240.83K-44.42%89.73K97.47%-14.18K-220.76%-688.22K101.21%4.07K78.48%-293.15K-92.88%161.43K-90,080.90%-560.58K314.70%569.9K43.71%-335.75K
End cash Position 402.33%400.1K-57.28%159.27K-67.10%69.55K-89.15%83.72K-89.15%83.72K-92.81%79.65K-84.91%372.8K4.29%211.36K282.06%771.95K282.06%771.95K
Free cash from 182.15%240.83K126.50%89.73K97.47%-14.18K43.60%-1.39M41.65%-195.93K78.48%-293.15K55.67%-338.57K-90,080.90%-560.58K-2,374.10%-2.46M45.57%-335.75K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data